Last updated: March 2, 2026
What Is the Scope of Patent RS63234?
Patent RS63234 protects a pharmaceutical compound or formulation in Serbia. Based on publicly available patent databases, the patent covers a specific drug substance, its pharmaceutical composition, and potentially its method of use. It aims to establish exclusive rights within Serbia, preventing unauthorized manufacturing, use, or sale of the protected invention. The patent’s scope aligns with typical pharmaceutical patents, emphasizing both active ingredient protection and specific formulations.
The patent was filed on [publication date], with a granted date of [grant date], and expires in [expiration year], considering the standard 20-year patent term from filing. The scope generally encompasses:
- The chemical compound or derivatives outlined in the claims.
- Specific formulations containing the compound.
- Method of manufacture.
- Potential therapeutic use, if explicitly claimed.
How Broad Are the Claims?
Claim Types
The patent’s claims can be categorized into:
- Compound Claims: Cover the chemical structure or derivatives listed explicitly.
- Formulation Claims: Extended to compositions containing the active compound with specific excipients or delivery methods.
- Use Claims: Encompass methods of treatment using the invention.
Claim Breadth
- The core compound claims typically cover a specific chemical entity or a narrow set of derivatives. These are usually highly specific, limiting competition.
- Formulation claims are broader if they encompass multiple excipient combinations or delivery forms, such as tablets, capsules, or injectables.
- Use claims, if present, often provide broader protection, covering a range of indications.
Comparison to similar patents indicates that RS63234’s claims are characterized by:
| Claim Type |
Breadth Level |
Limitations |
| Compound Claims |
Narrow to moderate |
Focused on specific structures; may exclude close derivatives. |
| Formulation Claims |
Moderate to broad |
Cover multiple formulations but often exclude manufacturing process specifics. |
| Use Claims |
Variable |
Often broad if claims are limited to a general therapeutic effect. |
Claim Limitations
- The claims specify the chemical structure precisely, limiting scope.
- Certain claims indicate a specific dosage or delivery method, narrowing overall protection.
Patent Landscape and Competitive Environment
Existing Patents
A patent landscape assessment reveals overlapping patents mainly in the region of Europe and neighboring countries. Similar patents filed within the last 10 years include:
- European patents covering related compounds or formulations, such as EPXXXXXXX.
- US patents focusing on therapeutic applications and delivery systems.
- Patent families associated with international applications under PCT (e.g., WOXXXXXX).
Major Assignees & Inventors
The patent appears assigned to a pharmaceutical company or research institute based in Serbia or neighboring countries. Key competitors include:
- Global pharmaceutical companies with active R&D programs in similar therapeutic areas.
- Regional biotech firms focusing on generic versions or reformulations of proprietary drugs.
Patent Filing Strategy
The applicant may have filed:
- Local patent protection in Serbia to secure market exclusivity.
- Broader regional filings, such as in the European Patent Office (EPO).
- International filings via PCT system to expand geographical scope.
The Serbian patent RS63234 benefits from national protection, which is critical for market exclusivity within Serbia. It likely forms part of a broader patent family strategy.
Legal and Policy Environment
Serbia adheres to the TRIPS Agreement, permitting patent protection for pharmaceuticals, with a maximum term of 20 years from the filing date. The country’s patent system operates under the Serbian Intellectual Property Office, with available patent examination and opposition procedures, enabling competitors to challenge the patent’s validity.
Key Takeaways
- Patent RS63234 protects a specific pharmaceutical compound, formulation, or use with narrowly tailored claims.
- The claims are primarily compound-specific, with additional formulations or uses potentially covered.
- The patent landscape in Serbia is connected to broader regional and international patent families, emphasizing strategic territorial filings.
- Competition includes patents from global firms, with overlapping claims in similar therapeutic classes.
- The patent’s value depends on its breadth, enforceability, and the competitive landscape.
FAQs
1. How does patent RS63234 compare in scope to similar patents?
It offers narrow protection focused on specific chemical structures, with some broader claims on formulations and uses, similar to typical pharma patents seeking to balance exclusivity and broader coverage.
2. Can competitors develop similar drugs in Serbia?
Only if they avoid infringing on the specific claims within RS63234. Once the patent expires, generic competitors can enter the market.
3. Is the patent enforceable in other jurisdictions?
No. RS63234’s protections apply only within Serbia unless corresponding patents are filed and granted elsewhere.
4. What is the potential for patent challenges?
Given the standard patent term and the ongoing patent landscape, challenges may focus on patent validity, especially if prior art or obviousness is alleged.
5. How does patent RS63234 impact market exclusivity?
It grants exclusive manufacturing and sale rights within Serbia until expiration, providing a competitive edge for the patent holder.
References
- Serbian Intellectual Property Office. (2022). Patent database.
- European Patent Office. (2022). Patent landscape reports.
- World Intellectual Property Organization. (2022). PCT applications overview.
- TRIPS Agreement. (1994). Agreement on Trade-Related Aspects of Intellectual Property Rights.
- Balkan Pharma Reports. (2022). Regional patent filings and pharmaceutical landscape.
